Molecular Hydrogen as a Novel Protective Agent Against Pre-Symptomatic Diseases
Molecular Hydrogen as a Novel Protective Agent against Pre-Symptomatic Diseases
Research hubs: Immune System

- Evidence type
- Review or commentary
- Authors
- Haru Yamamoto, Yusuke Ichikawa, Shin-Ichi Hirano, Bunpei Sato, Yoshiyasu Takefuji, Fumitake Satoh
- Journal
- International Journal of Molecular Sciences
- Year
- 2021
- PMID
- 34281264
- Study Type
- clinical
- Peer Reviewed
- Yes
- Cited by
- 15 (OpenAlex, as of November 2026)
- Country
- Japan
TL;DR
Scientists found that a gas called molecular hydrogen might help prevent diseases before you even feel sick by stopping harmful inflammation in your body, which is pretty cool because doctors normally can't catch these hidden diseases until symptoms show up.
Key Finding
Molecular hydrogen may suppress chronic inflammation by eliminating hydroxyl radicals and blocking a specific inflammatory pathway (NLRP3 inflammasome activation), potentially offering a preventive approach for diseases in their early, symptom-free stages.
Summary
This review examines how molecular hydrogen (H2) might help prevent diseases in their early stages before symptoms appear. The authors explain that chronic inflammation—a slow-building inflammatory response in the body—plays a role in many health conditions. Molecular hydrogen may reduce this inflammation by neutralizing harmful molecules called hydroxyl radicals, which contribute to oxidative stress (cellular damage). The review suggests H2 could be useful as a preventive tool, though the authors note that modern medicine currently cannot detect or treat these pre-symptomatic stages.
Practical Takeaway
This is a review article summarizing theoretical mechanisms rather than reporting new experimental results, and no human trials are mentioned. While the proposed mechanism is scientifically plausible, the practical benefit of hydrogen water for preventing pre-symptomatic diseases remains unproven in humans. Anyone interested in this area should await clinical trial evidence before making health decisions based on this review.
Abstract (excerpt)
Mibyou, or pre-symptomatic diseases, refers to state of health in which a disease is slowly developing within the body yet the symptoms are not apparent. Common examples of mibyou in modern medicine include inflammatory diseases that are caused by chronic inflammation. It is known that chronic…